NCT06218472 Assessment of the Impact of Early Treatment for Anorexia Nervosa in a Day Hospital on Food Symptomatology, the Outcome of Young Patients, and the Family Experience
| NCT ID | NCT06218472 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Condition | Anorexia Nervosa |
| Study Type | OBSERVATIONAL |
| Enrollment | 164 participants |
| Start Date | 2024-02-19 |
| Primary Completion | 2028-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 164 participants in total. It began in 2024-02-19 with a primary completion date of 2028-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
During the management of chronic illnesses, the day hospital (DH) serves as a brief and effective alternative to traditional hospitalization, offering access to multidisciplinary care. Indeed, patients can benefit from a range of therapeutic tools provided by a multidisciplinary care team while remaining in their living environment. Numerous structures exist for the management of eating disorders, but primarily for severe cases, often following hospitalization, before transitioning to outpatient care. There is no alternative for the initial management of these patients. The DH for the evaluation and early intervention in recent forms of anorexia nervosa at Maison de Solenn serves as a rapid entry point to specialized care. It allows for a thorough assessment and sustained management of eating disorders. Our hypothesis is that a multidisciplinary, intensive, and early intervention for patients with anorexia nervosa and their families in a day hospital would improve the short, medium, and long-term prognosis of the disease compared to conventional multidisciplinary outpatient care. It would also enhance the family's experience of this pathology and their coping skills.
Eligibility Criteria
Inclusion Criteria: * Adolescents in the age range of 12-18 years and their parents, * First-time consultation at the MDA for anorexia nervosa (according to DSM-5) evolving for less than 12 months, * Adolescents with clinical characteristics suitable for DH care. Exclusion Criteria: * Parents and/or children who do not speak French or cannot read or write, * Patients who have been followed by an eating disorder specialist in the past 12 months (at the MDA or elsewhere) or previously hospitalized for anorexia nervosa, * Patients who have undergone family therapy in the past, * Patients with BMI less than 13 kg/m2 for those under 14 years old, or less than 14 kg/m2 for those over 14 years old at the initial assessment, * Patients with a major psychiatric comorbidity or a metabolic condition interfering with eating or its regulation, * Patients and families in a crisis situation requiring immediate hospitalization.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06218472 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, studying Anorexia Nervosa. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06218472 currently recruiting?
Yes, NCT06218472 is actively recruiting participants. Contact the research team at corinne.blanchet@aphp.fr for enrollment information.
Where is the NCT06218472 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT06218472 clinical trial?
NCT06218472 is sponsored by Assistance Publique - Hôpitaux de Paris. The trial plans to enroll 164 participants.